P3 Health Partners (PIII) Fundamentals 2026 — Revenue Analysis | SniperIQ
P3 Health Partners (PIII) is a US-listed Healthcare company in Medical - Care Facilities with a market capitalization of
P3 Health Partners (PIII) is a US-listed Healthcare company in Medical - Care Facilities with a market capitalization of
P3 Health Partners (PIII) has a market capitalization of approximately
P3 Health Partners runs a net profit margin of -8.6%, a gross margin of 50.6%, and an operating margin of -15.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
P3 Health Partners reported revenue of
P3 Health Partners does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
P3 Health Partners carries a debt-to-equity ratio of -0.43x and a current ratio of 0.33x, with a market beta of 1.62. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For P3 Health Partners (PIII) the key facts are: market cap
Get P3 Health Partners's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.